With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world.
Ratings
4.9 / 5
64 ratings in the last 12 months
5
4
3
2
1
CEO
Mr. Lars Fruergaard Jorgensen$567.8B
Market Cap • 24/04/20241931
(há 93 anos)
1981
(43 years ago)
NYSE
Listagem
Bagsvaerd
54.393
N° de Empregados • 2022Valuation
Company FinancialsValuation Indicators
Valuation IndicatorsRetorno Histórico
NVOSó no Premium...
Visualize o retorno de longo prazo das ações. Dividendos e outros eventos são considerados.